Avacta Group PLC Sustainability Reports

Avacta Group PLC is a clinical-stage oncology biotechnology company that develops targeted cancer medicines. The company leverages its proprietary pre|CISION and Affimer technology platforms to engineer innovative peptide drug conjugates.

Sector: Manufacturing

Country: United Kingdom

Exchange: London Stock Exchange (AIM)

LEI: 2138009U3EG31OPMGH36

FIGI: BBG001SJRRZ8

10 reports from 2015 to 2025

• Avacta Group PLC 2025 Annual Report and Accounts
• Avacta Group PLC 2024 Annual Report and Accounts
• Avacta Group PLC 2023 Annual Report and Accounts
• Avacta Group PLC 2022 Report and Accounts
• Avacta Group PLC 2021 Report and Accounts